NuGen Medical Devices (TSXV:NGMD) EV-to-EBITDA : -5.01 (As of May. 29, 2024)

NuGen Medical Devices EV-to-EBITDA Chart

NuGen Medical Devices Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial								-2.07	-2.85	-7.75	-7.34	-4.23

Competitive Comparison of NuGen Medical Devices's EV-to-EBITDA

For the Medical Devices subindustry, NuGen Medical Devices's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NuGen Medical Devices's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NuGen Medical Devices's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where NuGen Medical Devices's EV-to-EBITDA falls into.

NuGen Medical Devices EV-to-EBITDA Calculation

NuGen Medical Devices's EV-to-EBITDA for today is calculated as:

NuGen Medical Devices's current Enterprise Value is C$27.98 Mil.
NuGen Medical Devices's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-5.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NuGen Medical Devices  (TSXV:NGMD) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

NuGen Medical Devices's PE Ratio for today is calculated as:

NuGen Medical Devices's share price for today is C$0.10.
NuGen Medical Devices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.037.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

NuGen Medical Devices EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of NuGen Medical Devices's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

NuGen Medical Devices (TSXV:NGMD) Business Description